October 9, 2002

Features

The Path to Personalized Medicine
The New, New Pharmacogenomics [Part 2]
The tactics have changed, sometimes dramatically, but hints of the promise of pharmacogenomics are finally starting to trickle in from studies of asthma, cancer, and drug response.
By Malorye A. Branca

Banking on Structures
An explosion of structural information is on the horizon, and the Protein Data Bank—the single international repository for data on the three-dimensional structures of biomolecules—is ready.
By Tracy Smith Schmidt

Calculating with DNA
Scientists have demonstrated that DNA computers can solve complex problems, but the verdict is out on whether they will ever become practical.
By Salvatore Salamone



News·Analysis 
Lab Instruments Come Online at Last
Reading, Writing, and Bioinformatics
RNAi Fever Heats Up Novel Drug Category Funding
Unleashing the Alpha Yeast
FDA Gives Biologics a New Look
New Pharma Cantata Sprouts from Cereon
ABI Building the Amazon.com of Biology
ISB Group Releases New Proteomics Software
Mixed Storage Made Simpler



Horizons

Apple's Efforts May Bear Fruit
INNOVATION Apple seems to be winning support from life science IT staffs. 


Michael Dell: Stand and Dell-iver
CONVERSATION John Dodge speaks with Dell about his company’s foray into the life sciences. 


Ups and Downs of Informatics Outsourcing
GUEST COMMENTARY The high-throughput drug discovery field requires an optimal IT platform. 


Georges Grinstein: Can You See the 88th Dimension?
CONVERSATION AnVil's founder talks to Mark D. Uehling about the future of data visualization. 


Columns & Departments

First Base | Kevin Davies
The 'Druggable Genome'


Buiness Watch | Debra Goldfarb · IDC
A Study in Contrasts 


Paper View | Kevin Davies
Affairs of the Heart 


New Products
ANALYSIS The Appliance of Sequence · Etrials Fine-Tunes EDC Tool · Tripos Ports Software Pair to New Platforms · TurboGenomics Offers TurboBench 2.0


The Dodge Retort | John Dodge
Dell Not "Buffaloed" by Bioinformatics